BIOVENTUS INC - A (BVS)
US09075A1088 - Common Stock
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...
Relative Strength Alert For Bioventus
Notable Two Hundred Day Moving Average Cross - BVS
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
DURHAM, N.C., March 12, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced fourth quarter and full-year financial results for the year ended December 31, 2023, and provided its financial guidance for full-year 2024.
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
DURHAM, N.C., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
DURHAM, N.C., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bioventus appoints Robert Claypoole as president and CEO (NASDAQ:BVS)
Bioventus announces the appointment of Robert Claypoole as CEO, succeeding interim CEO Anthony Bihl, and reaffirms its full-year financial guidance.
Bioventus Names Robert Claypoole as President and Chief Executive Officer
Seasoned Leader Brings More than Two Decades of Medical Device Experience and Proven Track Record of Driving Revenue and Operating Margin Growth
Bioventus Names Robert Claypoole as President and Chief Executive Officer
Seasoned Leader Brings More than Two Decades of Medical Device Experience and Proven Track Record of Driving Revenue and Operating Margin Growth...
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
DURHAM, N.C., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...
Top Buys by Top Brass: Interim CEO Bihl III's $165.1K Bet on BVS
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
Bioventus to Present at the Cantor Global Healthcare Conference
Bioventus to Present at the Cantor Global Healthcare Conference
DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that...
Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
DURHAM, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that...
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
DURHAM, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active...
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
DURHAM, N.C., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that...